癌症中的免疫代谢:一个系统的视角
Helena Moretti1, Giorgia Cioccoloni2, Esperanza Perucha1
1Centre for Inflammation Biology and Cancer Immunology, Department of Inflammation Biology, King's College London & Centre for Rheumatic Diseases, King's College London, London, United Kingdom.
Frontiers in immunology
|October 24, 2025
概括
癌症 癌症 癌症 癌症
科学领域:
- 免疫学和新陈代谢
背景情况:
- 癌症发病率正在上升,这对公众健康构成了重大挑战.
- 癌细胞通过不受控制的增殖逃避免疫监测,需要大量的能量.
- 瘤和免疫细胞对ATP和宏分子合成有很高的代谢需求.
研究的目的:
- 要总结抗瘤免疫反应的能量要求.
- 研究代谢过载和肥胖对抗瘤免疫力的影响.
- 探索患者的代谢状态如何影响免疫治疗的疗效.
主要方法:
- 细胞和组织代谢适应的系统视角分析.
- 在抗瘤免疫反应期间对能量需求的审查.
- 检查肥胖对免疫细胞代谢和功能的影响.
主要成果:
- 代谢过载和肥胖会破坏抗瘤免疫反应.
- 免疫疗法可以根据患者的代谢背景产生不同的结果.
- 了解代谢影响对于优化癌症治疗至关重要.
结论:
- 代谢适应对癌细胞和抗瘤免疫系统都至关重要.
- 肥胖和代谢功能障碍会损害抗瘤免疫力.
- 调整癌症预防和治疗以适应患者的新陈代谢概况至关重要.
相关概念视频
Tumor Immunotherapy
1.7K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
1.7K
Metastasis
6.4K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
6.4K
The Tumor Microenvironment
7.6K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
7.6K
Psychoneuroimmunology: Diabetes and Cancer
437
Chronic stress has been linked to both the onset and progression of serious health conditions, including Type 2 diabetes and cancer. Type 2 diabetes, a widespread chronic illness, is closely associated with obesity and insulin resistance, both of which often worsen under stress. Studies indicate that men experiencing high levels of chronic stress face a 45% higher risk of developing diabetes compared to those with minimal stress. Stress triggers physiological responses that elevate blood...
437
Adaptive Mechanisms in Cancer Cells
6.9K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
6.9K
Combination Therapies and Personalized Medicine
5.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.9K


